← Back to Search

Corticosteroid

Steroid Injections for Musculoskeletal Conditions

Phase 4
Recruiting
Led By Eugene Roh, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Capable of complying with the outcome instruments used
Average pain of greater than or equal to 4/10 over the last 7 days
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and at 2 weeks, 3 months, and 6 months post intervention
Awards & highlights

Study Summary

This trial will compare the effectiveness of two types of corticosteroid injections for treating pain from various musculoskeletal pathologies. It will also compare the side effect profiles of the two types of injections.

Eligible Conditions
  • Tendinopathy
  • Osteoarthritis
  • Shoulder Impingement

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are able to understand and complete the tests and surveys used in the study.
Select...
You have been experiencing pain that is rated 4 or higher on a scale of 0 to 10 for the past week.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and at 2 weeks, 3 months, and 6 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and at 2 weeks, 3 months, and 6 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean change in average pain from baseline
Secondary outcome measures
American Shoulder and Elbow Surgeons (ASES) Standardized Shoulder Assessment Form
Conversion to surgery
Number of repeat corticosteroid injections
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Particulate Corticosteroid InjectionExperimental Treatment1 Intervention
Intra-articular, peri-tendinous, or intra-bursal corticosteroid injection using 10-80mg of triamcinolone or 3-9mg of betamethasone depending on anatomical structure. Injections may be repeated up to 3 times in the 6 month study period based on physician discretion.
Group II: Non-particulate Corticosteroid InjectionExperimental Treatment1 Intervention
Intra-articular, peri-tendinous, or intra-bursal corticosteroid injection using 4-10mg of dexamethasone depending on anatomical structure. Injections may be repeated up to 3 times in the 6 month study period based on physician discretion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexamethasone
2007
Completed Phase 4
~2590

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,374 Previous Clinical Trials
17,332,729 Total Patients Enrolled
3 Trials studying Tendinopathy
55 Patients Enrolled for Tendinopathy
Eugene Roh, MD4.25 ReviewsPrincipal Investigator - Stanford University
Stanford University
5Patient Review
Dr. Roh is excellent. I sought a second opinion from him after other doctors recommended surgery for my wrist pain. He was very kind and gentle, and he took the time to examine my condition thoroughly. He explained my diagnosis in plain, simple language. After a few months of conservative treatment with Dr. Roh, I am pain free! I highly recommend Dr. Roh to all my friends!

Media Library

Betamethasone (Corticosteroid) Clinical Trial Eligibility Overview. Trial Name: NCT04278833 — Phase 4
Tendinopathy Research Study Groups: Particulate Corticosteroid Injection, Non-particulate Corticosteroid Injection
Tendinopathy Clinical Trial 2023: Betamethasone Highlights & Side Effects. Trial Name: NCT04278833 — Phase 4
Betamethasone (Corticosteroid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04278833 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~44 spots leftby Mar 2025